| Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease S Spoerl, NR Mathew, M Bscheider, A Schmitt-Graeff, S Chen, T Mueller, ... Blood 123 (24), 3832-3842, 2014 | 427 | 2014 |
| Continuous T cell receptor signals maintain a functional regulatory T cell pool JC Vahl, C Drees, K Heger, S Heink, JC Fischer, J Nedjic, N Ohkura, ... Immunity 41 (5), 722-736, 2014 | 328 | 2014 |
| The Nlrp3 inflammasome regulates acute graft-versus-host disease D Jankovic, J Ganesan, M Bscheider, N Stickel, FC Weber, G Guarda, ... Journal of Experimental Medicine 210 (10), 1899-1910, 2013 | 252 | 2013 |
| RIG-I/MAVS and STING signaling promote gut integrity during irradiation-and immune-mediated tissue injury JC Fischer, M Bscheider, G Eisenkolb, CC Lin, A Wintges, V Otten, ... Science translational medicine 9 (386), eaag2513, 2017 | 118 | 2017 |
| RIG-I activation is critical for responsiveness to checkpoint blockade S Heidegger, A Wintges, F Stritzke, S Bek, K Steiger, PA Koenig, S Göttert, ... Science Immunology 4 (39), eaau8943, 2019 | 109 | 2019 |
| RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade S Heidegger, D Kreppel, M Bscheider, F Stritzke, T Nedelko, A Wintges, ... EBioMedicine 41, 146-155, 2019 | 42 | 2019 |
| A20 restrains thymic regulatory T cell development JC Fischer, V Otten, M Kober, C Drees, M Rosenbaum, M Schmickl, ... The Journal of Immunology 199 (7), 2356-2365, 2017 | 38 | 2017 |
| Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines S Bek, F Stritzke, A Wintges, T Nedelko, DFR Böhmer, JC Fischer, T Haas, ... Oncoimmunology 8 (4), e1570779, 2019 | 30 | 2019 |
| Card9 controls Dectin‐1‐induced T‐cell cytotoxicity and tumor growth in mice T Haas, S Heidegger, A Wintges, M Bscheider, S Bek, JC Fischer, ... European Journal of Immunology 47 (5), 872-879, 2017 | 30 | 2017 |
| Assessment of mucosal integrity by quantifying neutrophil granulocyte influx in murine models of acute intestinal injury JC Fischer, A Wintges, T Haas, H Poeck Cellular immunology 316, 70-76, 2017 | 27 | 2017 |
| Roquin Paralogs Differentially Regulate Functional NKT Cell Subsets C Drees, JC Vahl, S Bortoluzzi, KD Heger, JC Fischer, FT Wunderlich, ... The Journal of Immunology 198 (7), 2747-2759, 2017 | 18 | 2017 |
| XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice. N Müller, JC Fischer, M Yabal, T Haas, H Poeck, PJ Jost European Journal of Immunology 49 (3), 504-507, 2019 | 13 | 2019 |
| Minimally manipulated murine regulatory T cells purified by reversible Fab Multimers are potent suppressors for adoptive T‐cell therapy F Mohr, JC Fischer, M Nikolaus, C Stemberger, S Dreher, A Verschoor, ... European Journal of Immunology 47 (12), 2153-2162, 2017 | 13 | 2017 |
| Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells JC Fischer, M Bscheider, S Göttert, E Thiele Orberg, SE Combs, ... Scientific Reports 9 (1), 14955, 2019 | 11 | 2019 |
| A20 deletion in T cells modulates acute graft‐versus‐host disease in mice JC Fischer, V Otten, K Steiger, M Schmickl, J Slotta‐Huspenina, R Beyaert, ... European Journal of Immunology 47 (11), 1982-1988, 2017 | 11 | 2017 |
| Regeneration after radiation-and immune-mediated tissue injury is not enhanced by type III interferon signaling JC Fischer, CC Lin, S Heidegger, A Wintges, M Schlapschy, M Beudert, ... International Journal of Radiation Oncology* Biology* Physics 103 (4), 970-976, 2019 | 9 | 2019 |
| Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade KM Kraus, JC Fischer, KJ Borm, MME Vogel, SU Pigorsch, M Devečka, ... Scientific reports 11 (1), 7624, 2021 | 5 | 2021 |
| Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation E Thiele Orberg, E Meedt, A Hiergeist, J Xue, P Heinrich, J Ru, S Ghimire, ... Nature Cancer, 1-22, 2024 | 2 | 2024 |
| Pneumonitis after stereotactic thoracic radioimmunotherapy with checkpoint inhibitors: exploration of the dose–volume–effect correlation KM Kraus, C Bauer, B Feuerecker, JC Fischer, KJ Borm, D Bernhardt, ... Cancers 14 (12), 2948, 2022 | 2 | 2022 |
| Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse Model of Human Pancreatic Cancer S Dobiasch, S Kampfer, K Steiger, D Schilling, JC Fischer, TE Schmid, ... Cancers 13 (22), 5656, 2021 | 2 | 2021 |
